Gene therapy for hematopoietic and immune disorders

Bone Marrow Transplantation

Volumn 18, Issue SUPPL. 3, 1996, Pages

  Kohn, D B ^a  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

Adeno associated virus; Gene therapy; Hematopoietic stem cells; Retroviral vectors; Severe combined immunodeficiency

Indexed keywords

ADENOSINE DEAMINASE; VIRUS VECTOR;

COMBINED IMMUNODEFICIENCY; CONFERENCE PAPER; ENZYME DEFICIENCY; GENE THERAPY; GENETIC TRANSDUCTION; HEMATOLOGIC DISEASE; HEMATOPOIETIC STEM CELL; HEMOGLOBINOPATHY; HUMAN; IMMUNE DEFICIENCY; IMMUNOPATHOLOGY; LEUKOCYTE; LYSOSOME STORAGE DISEASE; MURINE LEUKEMIA VIRUS; NEWBORN; PRIORITY JOURNAL; RETROVIRUS; UMBILICAL CORD BLOOD;

ADENOSINE DEAMINASE; ANIMALS; DEPENDOVIRUS; DISEASE MODELS, ANIMAL; DOGS; FETAL BLOOD; GENE THERAPY; GENETIC VECTORS; HAPLORHINI; HEMATOLOGIC DISEASES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNE SYSTEM DISEASES; INFANT, NEWBORN; METABOLISM, INBORN ERRORS; MICE; NEOPLASMS; RETROVIRIDAE; SEVERE COMBINED IMMUNODEFICIENCY;

EID: 0030473830     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (23)

1. Parkman R. The application of bone marrow transplantation to the treatment of genetic diseases. Science 1986; 232: 1373-1378.
2. Anderson WF. Prospects for human gene therapy. Science 1984; 226: 401-409.
3. Kohn DB. The current status of gene therapy using hematopoietic stem cells. Curr Opin Ped 1995; 7: 56-63.
4. Miller AD. Retroviral vectors. Curr Top Microbiol Immunol 1992; 158: 1-24.
5. Crystal RG. Transfer of genes to humans: early lessons and obstacles to success. Science 1995; 270: 404-410.
6. Bodine DM, Karlsson S, Nienhuis AW. Combination of interleukins 3 and 6 preserves stem cell function in culture and enhances retrovirus-mediated gene transfer into hematopoietic stem cells. Proc Natl Acad Sci USA 1986; 86: 8897-8901.
7. Van Beusechem VW, Kukler A, Heidt PJ, Valerio D. Long-term expression of human adenosine deaminase in rhesus monkeys transplanted with retrovirus-infected bone marrow cells. Proc Natl Acad Sci USA 1992; 89: 7640-7644.
8. + bone marrow cells. Blood 1993; 82: 1975-1980.
9. Kiem HP, Karovsky B, von Kalle C et al. Retrovirus-mediated gene transduction into canine peripheral blood repopulating cells. Blood 1994; 83: 1467-1473.
10. Bienzle D, Abrams-Ogg AC, Kruth SA et al. Gene transfer into hematopoietic stem cells: long-term maintenance of in vitro activated progenitors without marrow ablation. Proc Natl Acad Sci USA 1994; 91: 350-354.
11. Nolta JA, Kohn DB. Comparison of the effects of growth factors on retroviral vector-mediated gene transfer and the proliferative status of human hematopoietic progenitor cells. Hum Gene Ther 1990; 1: 257-268.
12. Nolta JA, Crooks GM, Overell RW et al. Retroviral vector-mediated gene transfer into primitive human hematopoietic progenitor cells: effects of mast cell growth factor (MGF) combined with other cytokines. Exp Hematol 1992; 20: 1065-1071.
13. Moore KA, Deisseroth AB, Reading CL et al. Stromal support enhances cell-free retroviral vector transduction of human bone marrow long-term culture-initiating cells. Blood 1992; 79: 1393-1399.
14. Nolta JA, Smogorzewska EM, Kohn DB. Analysis of optimal conditions for retroviral-mediated transduction of primitive human hematopoietic cells. Blood 1995; 86: 101-110.
15. Moritz T, Patel VP, Williams DA. Bone marrow extracellular matrix molecules improve gene transfer into human hematopoietic celts via retroviral vectors. J Clin Invest 1994; 93: 1451-1457.
16. - progenitor cells. Blood 1991; 77: 1218-1225.
17. - cells in cord blood and bone marrow. Blood 1995; 86: 3745-3753.
18. Brenner MK, Rill DR, Moen RC et al. Gene-marking to trace origin of relapse after autologous bone-marrow transplantation. Lancet 1993; 341: 85-86.
19. Deisseroth AB, Zu Z, Claxton D et al. Genetic marking shows that Ph+ cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML. Blood 1994; 83: 3068-3076.
20. Dunbar CE, Cottler-Fox M, O'Shaughnessy JA et al. Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation. Blood 1995; 85: 3048-3057.
21. Brenner MK, Rill DR, Holladay MS et al. Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients. Lancet 1993; 342: 1134-1137.
22. Kohn DB, Weinberg KI, Nolta JA et al. Engraftment of gene-modified cells from umbilical cord blood in neonates with adenosine deaminase deficiency. Nature Med 1995; 1: 1017-1026.
23. Muzyczka N. Use of adeno-associated virus as a general transduction vector for mammalian cells. Curr Top Micro Immunol 1992; 158: 97-129.